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modeling in physiology
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The classic (hereafter cold) and the labeled (hereafter hot)
minimal models are powerful tools to investigate glucose
metabolism. The cold model provides, from intravenous glu-
cose tolerance test (IVGTT) data, indexes of glucose effective-
ness (SG) and insulin sensitivity (SI) that measure the effect
of glucose and insulin, respectively, to enhance glucose disap-
pearance and inhibit endogenous glucose production. The hot
model provides, from hot IVGTT data, indexes of glucose
effectiveness (S*G) and insulin sensitivity (S*I) that, respec-
tively, measure the effects of glucose and insulin on glucose
disappearance only. Recent reports call for a reexamination of
some of the assumptions of the minimal models. We have
previously pointed out the criticality of the single-compart-
ment description of glucose kinetics on which both the
minimal models are founded. In this paper we evaluate the
impact of single-compartment undermodeling on SG, SI, S*G,
and S*I by using a two-compartment model to describe the
glucose system. The relationships of the minimal model
indexes to the analogous indexes measured with the glucose
clamp technique are also examined. Theoretical analysis and
simulation studies indicate that cold indexes are more af-
fected than hot indexes by undermodeling. In particular, care
must be exercised in the physiological interpretation of SG,
because this index is a local descriptor of events taking place
in the initial portion of the IVGTT. As a consequence, SG not
only reflects glucose effect on glucose uptake and production
but also the rapid exchange of glucose between the accessible
and nonaccessible glucose pools that occurs in the early part
of the test.
insulin sensitivity; glucose effectiveness; mathematical model;
intravenous glucose tolerance test; glucose clamp
THE INTRAVENOUS GLUCOSE TOLERANCE TEST (IVGTT),
standard or modified with a tolbutamide or insulin
injection, interpreted with the classic minimal model of
glucose disappearance (hereafter cold minimal model)
(6–10), is a powerful research tool to investigate glu-
cose metabolism in physiopathological and epidemiologi-
cal studies; more than 350 papers have appeared until
1998. The model provides two metabolic indexes mea-
suring glucose effectiveness (SG) and insulin sensitivity
(SI). SG and SI are composite parameters, i.e., they
measure the overall effect of glucose and insulin, respec-
tively, to enhance glucose disappearance (Rd) and in-
hibit endogenous glucose production (EGP). To segre-
gate the effect of glucose and insulin on Rd and EGP, a
labeled (hereafter hot) IVGTT has been introduced, i.e.,
a glucose tracer has been added to the glucose bolus (2,
17, 19, 23). The hot IVGTT interpreted with a minimal
model of labeled glucose disappearance (hereafter hot
minimal model) provides new indexes of glucose effec-
tiveness (S*G) and insulin sensitivity (S*I) that measure
the effects of glucose and insulin, respectively, on
glucose disposal only (19, 23).
Several investigators have recently reexamined some
of the minimal model assumptions (16–18, 22–24, 27,
30, 32). We have found some unexpected relationships
between the cold and hot indexes (17, 19); in addition,
we have observed that when EGP is derived by combin-
ing the cold and hot minimal models, its time course is
physiologically absurd (17). Quon et al. (30) have shown
in a study on insulin-dependent diabetes mellitus
patients that SG is likely to be overestimated. Saad et
al. (32) have shown that SI obtained from an insulin-
modified IVGTT is well correlated but markedly under-
estimated compared with the insulin sensitivity index
obtained with the glucose clamp technique. Finegood
and Tzur (24) have shown in dogs that decreased SG
associated with decreased insulin response is an arti-
fact of the minimal model method and that SG is poorly
correlated with the glucose effectiveness index obtained
with the glucose clamp technique.
We have suggested two possible areas of model error
(16, 18, 22, 23, 38): the monocompartmental structure
of both the minimal models and the description of EGP
embodied in the cold minimal model. We have shown
that the monocompartmental structure is the major
area responsible for the implausible EGP profile and
0193-1849/99 $5.00 Copyright r 1999 the American Physiological Society E1171
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that a two-compartment hot minimal model provides
not only a reliable profile of EGP by deconvolution (14,
39) but also tracer-based indexes of glucose effective-
ness, insulin sensitivity, and plasma clearance rate
(37). Recently, we have used the two-compartment
paradigm (18, 22, 38) to explain the findings of Quon et
al. (30) and Saad et al. (32) and the poor agreement
between SG and the clamp-based index of glucose
effectiveness (24).
The aim of the present paper is to use a two-
compartment model of glucose metabolism to explain
the mechanisms by which monocompartmental under-
modeling affects both cold and hot minimal model
indexes.
Glossary
A1, A2; A*1, A*2 Coefficients of two-exponential cold and
hot glucose decay during an IVGTT
at basal insulin, mg/dl and dmp/ml
(for a radiolabeled IVGTT)
D, D* Cold and and hot glucose IVGTT dose,
mg/kg and dpm/kg, respectively
EGP(t) Endogenous glucose production,
mg·kg21 ·min21
EGPb Endogenous glucose production in the
basal state, mg·kg21 ·min21
g(t), g*(t) Cold and hot glucose concentration in
plasma, mg/dl and dpm/ml, respec-
tively
g(0), g*(0) Minimal model estimates of cold and
hot glucose concentration at time 01,
mg/dl and dpm/ml, respectively
gb Plasma glucose concentration in basal
state, mg/dl
g2(t), g˜*2(t) Cold and hot glucose concentration in
the second pool of the two-compart-
ment model, mg/dl and dpm/ml, re-
spectively
g˜2(t), g˜*2(t) As above, with insulin-dependent re-
moval moved to the accessible pool,
mg/dl and dpm/ml, respectively
GE, GE* Cold and hot glucose effectiveness of
the two-compartment model, ml·kg21 ·
min21
GEb Cold glucose effectiveness measured
from the area under the glucose ex-
cursion during an IVGTT at basal
insulin, ml·kg21 ·min21
GINF(t) Glucose infusion rate during the glu-
cose clamp, mg·kg21 ·min21
k21, k12, k02, kd, Rate parameters of the two-compart-
ment model, min21
k22 k22 5 k121k02, min21
ka Rate constant of the remote insulin
compartment in the two-compart-
ment model, min21
kbd, kbp Parameters describing insulin effect on
glucose uptake and EGP in the two-
compartment model, min22·ml·µU21,
respectively
kp Parameter describing glucose effect on
EGP in the two-compartment model,
min21
i(t) Insulin concentration in plasma, µU/ml
ib Plasma insulin concentration in the
basal state, µU/ml
IS,IS* Cold and hot insulin sensitivity of the
two-compartment model, ml·kg21·
min21 per µU/ml
PCRb Plasma glucose clearance in the basal
state, ml·kg21 ·min21
p1, p2; p*1, p*2 Cold and hot minimal model rate pa-
rameters, min21
qi(t), q*i(t) Cold and hot glucose mass in ith com-
partment of the two-compartment
model (i 5 1, 2), mg and dpm, respec-
tively
Rd(t) Glucose disappearance rate from the
accessible pool, mg·kg21 ·min21
Rd,0 Nonzero intercept of the relationship
Rd vs. g, mg·kg21 ·min21
SG, S*G Minimal model estimates of cold and
hot glucose effectiveness, min21
SG(clamp),SG,d(clamp) Glucose clamp measurements of cold
and hot glucose effectiveness, ml·kg21·
min21
SI, S*I Minimal model estimates of cold and
hot insulin sensitivity, min21 ·
µU·ml21
SI(clamp),SI,d(clamp) Glucose clamp measurements of cold
and hot insulin sensitivity, ml·kg21 ·
min21 ·µU21 ·ml
t Time, min
V,V* Cold and hot minimal model volume,
ml/kg
V1 Volume of the accessible pool of the
two-compartment model, ml/kg
VT Total glucose distribution volume,
ml/kg
x(t), x*(t) Cold and hot minimal model insulin
action, min21
X(t) Two-compartment model insulin ac-
tion, i.e., X 5 xp1xd, min21
X˜(t) As above, with insulin-dependent re-
moval moved to the accessible pool,
i.e., X˜ 5 xp 1 x˜d, min21
xd(t) Two-compartment model insulin ac-
tion on glucose uptake, min21
x˜d(t), x˜*d(t) As above, with insulin-dependent re-
moval moved to the accessible pool
(the asterisk denotes tracer-based
calculation), min21
xp(t) Two-compartment model insulin ac-
tion on EGP, min21
a(t) Deviation of hot glucose decay from a
two-exponential function during an
IVGTT at basal insulin, dpm/ml
g g 5 k21k12, min22
l1, l2; l*1, l*2 Fast and slow eigenvalues of the cold
and hot glucose decay during an
IVGTT at basal insulin, min21
THE COLD AND HOT MINIMAL MODELS
The Cold Model
The cold minimal model (Fig. 1) interprets plasma
glucose and insulin concentrations measured during an
IVGTT (standard, or modified with a tolbutamide or
E1172 MINIMAL MODEL INDEXES
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insulin injection). The model in its uniquely identifiable
parametrization (6, 8, 9, 23) is described by
g˙(t) 5 2[p1 1 x(t)]g(t) 1 p1gb g(0) 5 gb 1
D
V
x˙(t) 5 2p2x(t) 1 p3[i(t) 2 ib] x(0) 5 0
(1)
where g is plasma glucose concentration (gb denotes its
basal end test value), i is plasma insulin concentration
(ib denotes its basal end test value), D is the glucose
dose in the bolus, V is the glucose distribution volume, x
is insulin action [x 5 (k41k6)i8, where i8 is insulin in the
remote compartment], and the pi values are param-
eters related to the ki values: p1 5 k11k5, p2 5 k3, p3 5
k2(k41k6).
Parameters p1, p2, p3, and V can be estimated from
glucose and insulin data by use of nonlinear least
squares parameter estimation techniques (13). From
them one can calculate the cold indexes of glucose
effectiveness, SG, and insulin sensitivity, SI, as
SG 5 p1 5 k1 1 k5 (min21)
SI 5
p3
p2
5
k2(k4 1 k6)
k3
(min21 · µU21 · ml)
(2)
SG and SI measure the effects of glucose and insulin,
respectively, on both Rd and EGP. In fact, because SG is
a function not only of k1, but also of k5 (see Fig. 1), it
measures the ability of glucose at basal insulin to
stimulate Rd and to inhibit EGP. Similarly, SI is a
function not only of k1, k3, k4, but also of k6, and thus
measures the ability of insulin to enhance the glucose
stimulation of Rd and inhibition of EGP. Parameter p2 is
the rate constant of the remote insulin compartment
and governs the speed of rise and decay of insulin
action.
Reference values for SG and SI have been obtained
from the analysis of insulin and cold glucose data of a
hot IVGTT performed in 25 normal young adults.
Values for SG and SI were, respectively, 0.026 6 0.002
min21 and 7.3 6 1.0 3 1024 min21 ·µU21 ·ml. The mean
precision of SG and SI estimates was 49 and 18%,
respectively. Volume V was estimated as 1.66 6 0.05
dl/kg.
The Hot Model
The hot minimal model (Fig. 2) interprets plasma hot
glucose and insulin concentrations measured during a
hot IVGTT, that is, an IVGTT (standard, or modified
with a tolbutamide or insulin injection) in which a
glucose tracer (radioactive or stable isotope) is added to
the glucose bolus. Because hot glucose concentration
only reflects Rd, the hot model yields indexes measuring
glucose and insulin effect on Rd only. The model in its
uniquely identifiable parametrization (2, 17, 19, 23) is
described by
g˙*(t) 5 2[p*1 1 x*(t)]g*(t) g*(0) 5
D*
V*
x˙*(t) 5 2p*2x(t) 1 p*3[i(t) 2 ib] x*(0) 5 0
(3)
where the symbols are the same as in Eq. 1, with the
asterisk denoting tracer-related variables and param-
eters. In particular, D* is the hot glucose dose, V* is the
hot glucose distribution volume, x* is hot insulin action
Fig. 1. The cold minimal model. See glossary for
definition of terms.
Fig. 2. The hot minimal model. See glossary for definition of terms.
E1173MINIMAL MODEL INDEXES
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(proportional to remote insulin i8*, x* 5 k4i8*), and the
p*i values are parameters related to the ki values: p*1 5
k1, p*2 5 k3, and p*3 5 k2k4.
Parameters p*1, p*2, p*3, and V* can be estimated from
insulin and hot glucose data by using nonlinear least
squares parameter estimation techniques (13). From
them one can calculate the hot indexes of glucose
effectiveness, S*G, and insulin sensitivity, S*I, as
S*G 5 p*1 5 k1 (min21)
S*I 5
p*3
p*2
5
k2k4
k3
(min21 · µU21 · ml)
(4)
S*G measures the ability of glucose at basal insulin to
stimulate Rd, and S*I measures the ability of insulin to
enhance glucose stimulation of Rd. Parameter p*2 is the
rate constant of the remote insulin compartment and
governs the speed of rise and decay of hot insulin
action.
Values for S*G and S*I have been obtained in the same
25 normal young subjects from the analysis of insulin
and hot glucose data of the hot IVGTT. Data on 15
subjects have already been reported in previous publi-
cations (2, 17). Stable isotopes ([6-2H2]glucose and
[2-2H]glucose) were employed in 19 studies, whereas a
radioactive isotope ([3-3H]glucose) was employed in 6
studies. Values for S*G and S*I were, respectively,
0.0082 6 0.0003 min21 and 9.0 6 1.2 3 1024
min21 ·µU21 ·ml. The mean precision of S*G and S*I
estimates was 4 and 5%, respectively. Volume V* was
estimated as 1.88 6 0.06 dl/kg.
Cold vs. Hot Indexes
The results of this study confirm previously observed
trends (2, 17, 19): SG is about three times higher than
S*G (P , 0.001), and SI is lower than S*I (P , 0.05). Of
note is that these trends are also present when the
indexes are estimated from an insulin-modified hot
IVGTT (unpublished results). Thanks to the larger
data base, it is now possible to assess the degree of
correlation between SG and S*G and between SI and S*I
(Fig. 3). Whereas a strong correlation exists between SI
and S*I (r 5 0.84, P , 0.001), SG and S*G are uncorrelated
(r 5 0.17, P . 0.15).
Some of the above results are unexpected and sug-
gest the presence of some model error. SG is higher than
S*G, in keeping with the theoretical expectation, but
their ratio is too high compared with that of the
analogous clamp-based indexes of cold, SG(clamp), and
hot, SG,d(clamp), glucose effectiveness (subscript ‘‘d’’ de-
notes disappearance). In fact, whereas SG is about three
times higher than S*G, SG(clamp) is only 1.5 times higher
than SG,d(clamp) (11). Also, the complete lack of correla-
tion between SG and S*G is surprising, because SG(clamp)
and SG,d(clamp) are presumably well correlated, given
that SG,d(clamp) is the major determinant (,2/3) of SG(clamp)
(11).
The time courses of cold and hot insulin actions (Fig.
4) also show an unexpected trend. The cold minimal
model assumes that insulin actions on Rd and EGP
have the same timing, but the time lag between x and
x* (caused by p2 being lower than p*2) violates this
assumption. In addition, the profile of insulin action on
EGP, calculated as the difference x 2 x*, is physiologi-
cally implausible (17).
Fig. 3. Correlation between cold and
hot indexes of glucose effectiveness (A)
and insulin sensitivity (B). See glos-
sary for definition of terms.
Fig. 4. Cold and hot insulin action during a standard hot intravenous
glucose tolerance test (IVGTT) in a representative subject.
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Finally, the finding SI , S*I is unexpected, because SI,
which measures insulin effect on both Rd and EGP,
should be higher than S*I, which measures insulin effect
on Rd only. This incongruity is not present when insulin
sensitivity is assessed with the glucose clamp tech-
nique: in Ref. 10 SI(clamp) exceeded SI,d(clamp) [denoted as
SI,p(clamp) in that paper] in each subject, with SI(clamp) and
SI,d(clamp) being the clamp version analogous to SI and S*I,
respectively.
The above inconsistencies are symptoms of model
error. Two possible areas of error are the description of
glucose and insulin effect on EGP embodied in the cold
model and the single-compartment description of glu-
cose kinetics (17, 18, 23). In this paper we focus on the
latter only.
A TWO-COMPARTMENT MODEL OF THE GLUCOSE
SYSTEM DURING THE IVGTT
To investigate the mechanisms by which single-
compartment undermodeling affects the minimal model
indexes, we developed a physiologically based two-
compartment model to describe the glucose system
during the IVGTT. The model, shown in Fig. 5, is
described in detail in APPENDIX A. Briefly, the model
describes both glucose kinetics and EGP during the
IVGTT. The description of glucose kinetics is the same
as that of the two-compartment minimal model pro-
posed in Refs. 14 and 37. It is assumed that insulin-
independent glucose disposal occurs in the accessible
compartment, whereas insulin-dependent glucose dis-
posal occurs in the nonaccessible compartment. Consis-
tent with known physiology, insulin-independent glu-
cose uptake accounts for the inhibitory effect of
hyperglycemia on glucose clearance. It consists of two
components, one constant and the other proportional to
glucose concentration. Insulin-dependent glucose up-
take is parametrically controlled by insulin in a remote
insulin compartment. The assumption is made that, in
the basal state, insulin-dependent glucose disposal is
three times insulin-independent glucose disposal. EGP
is described using the same functional description
embodied in the cold minimal model (8, 17, 19, 23), thus
allowing us to focus on the bias due to single-
compartment undermodeling only. In fact, EGP inhibi-
tion is assumed to be proportional to the increment of
glucose concentration above basal and to the product of
glucose concentration and insulin action. In addition,
as in the minimal model, insulin action on EGP is
assumed to have the same timing as insulin action on
glucose uptake.
To ascertain the ability of this model to describe
satisfactorily the glucose system during the IVGTT, we
used Monte Carlo simulation (details in APPENDIX B).
Briefly, the two-compartment model with mean param-
eters was used to generate noise-free cold and hot
glucose data during a hot IVGTT. The mean insulin
profile of either a standard or an insulin-modified
IVGTT was used as input to the model. Noise of
appropriate characteristics was added to the data, and
the noisy IVGTT data sets were then interpreted with
the minimal models. We reasoned that, if the two-
compartment model is a realistic representation of the
glucose system during the IVGTT, the minimal model
parameters estimated from the simulated data should
be close to those estimated from real data and should
exhibit the same trends discussed above. In addition,
the relationships between the minimal model esti-
mates of glucose effectiveness and insulin sensitivity
and the analogous two-compartment model indexes
should be similar to those observed experimentally
between the minimal model and clamp-based indexes.
These hypotheses were all confirmed. Table 1 reports
the mean results of the identification of the two mini-
mal models from simulated IVGTT data. The values of
SG, SI, S*G, and S*I are similar to those reported in the
literature. In particular, SI is close to the value found by
Saad et al. (32) in normal subjects. This similarity is
noteworthy, because the insulin sensitivity of the two-
compartment model has been chosen equal to the one
found by Saad et al. in normal subjects with the clamp
technique (see APPENDIX A). Of note is that all the
experimentally observed inconsistencies between cold
Fig. 5. The two-compartment simulation model. See glossary for
definitions of terms.
Table 1. Monte Carlo simulation results: cold and hot
minimal model indexes estimated from standard
and insulin-modified IVGTT
Cold Minimal Model Hot Minimal Model
SG,
min21
SI, 31024 dl ·
kg21 ·min21 ·
µU21 ·ml
V,
dl/kg
S*G,
min21
S*I, 31024 dl ·
kg21 ·min21 ·
µU21 ·ml
V*,
dl/kg
Standard
IVGTT 0.021 2.9 2.0 0.0102 3.2 2.1
Insulin-
modified
IVGTT 0.020 3.3 1.9 0.0098 3.5 2.2
IVGTT, intravenous glucose tolerance test; SG and S*G, cold and hot
indexes of glucose effectiveness, respectively; SI and S*I, cold and hot
indexes of insulin sensitivity, respectively; V and V*, cold and hot
minimal model volumes, respectively.
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and hot parameters are present: SI is lower than S*I, SG
is twice S*G, and hot insulin action is faster than cold
because p*2 . p2 (e.g., for the simulated standard
IVGTT, p*2 5 0.069 vs. p2 5 0.027 min21).
How do the minimal model indexes of glucose effec-
tiveness and insulin sensitivity compare with the ‘‘true’’
indexes of the two-compartment model? To answer this
question we derived indexes of glucose effectiveness,
insulin sensitivity, and basal plasma clearance rate for
the two-compartment model (details are provided in
APPENDIX C). Of note is that these indexes are expressed
in the same units as those of the corresponding clamp-
based indexes. To express also the minimal model
indexes in the same units, SG and SI were multiplied by
V, and S*G and S*I were multiplied by V*, in keeping with
the analysis reported in Vicini et al. (37). The values of
the two-compartment and minimal model indexes are
reported in Table 2. One can see that the cold minimal
model overestimates glucose effectiveness and underes-
timates insulin sensitivity, in keeping with the experi-
mental results (24, 32). S*GV* slightly underestimates
basal glucose clearance and markedly overestimates
hot glucose effectiveness, in keeping with the trend
observed in Ref. 37. Specifically, S*G is virtually identi-
cal to the basal fractional glucose clearance of the
two-compartment model (e.g., S*G from the standard
IVGTT is 0.0102 min21, and PCR/VT 5 0.0096 min21).
This is consistent with the results of the S*G validation
study in dogs (19). S*IV* slightly underestimates the hot
insulin sensitivity of the two-compartment model, but
no studies are available in the literature comparing the
hot minimal model insulin sensitivity with the analo-
gous clamp-based index.
All in all, these results support the notion that the
two-compartment model is a satisfactory representa-
tion of the glucose system during the IVGTT. We can
thus use this model with confidence to analyze the
impact of monocompartmental undermodeling on the
cold and hot minimal model indexes and elucidate their
relationships with the analogous clamp-based mea-
sures of glucose effectiveness and insulin sensitivity.
COLD GLUCOSE EFFECTIVENESS
Effects of Monocompartmental Undermodeling on SG
To examine the effects of the monocompartmental
approximation on SG, we build on Ref. 18 and, for the
sake of clarity, we outline the reasoning followed in that
paper. Usually, SG is estimated from an IVGTT in which
an insulin response is present and glucose decay de-
pends on both glucose and insulin. However, the effects
of the monocompartmental approximation on SG can be
more easily determined if one first analyzes what
happens during an IVGTT in which insulin is main-
tained at the basal level. Under these conditions,
insulin action is identically equal to zero (Eq. 1), and
the minimal model is described by a first-order linear
differential equation
g˙(t) 5 2SG[g(t) 2 gb] g(0) 5 gb 1
D
V
(5)
Solving Eq. 5 for glucose concentration and defining
Dg(t) 5 g(t) 2 gb, one has
Dg(t) 5
D
V
e2SGt (6)
Thus the minimal model predicts that the decay of
glucose concentration during an IVGTT at basal insu-
lin is monoexponential, with SG as rate constant. The
fractional decay rate of incremental glucose concentra-
tion (kG, min21), namely the fraction of glucose concen-
tration above basal that declines per unit time, is
constant and equal to SG
kG(t) 5 2Dg˙(t)/Dg(t) 5 SG (7)
The true glucose system, however, is not monocom-
partmental. Using the two-compartment model pre-
sented in the previous section, one can show (APPENDIX
D) that glucose decay during an IVGTT at basal insulin
is described by two exponentials
Dg(t) 5 D(A1e2l1t 1 A2e2l2t) (8)
where l1 and l2 (min21) are the fast and slow compo-
nents of glucose decay, respectively (l1 . l2). Because of
the presence of two time constants, the fractional decay
rate of incremental glucose concentration is no longer
constant, but time varying
kG(t) 5 2Dg˙(t)/Dg(t) 5
A1l1e2l1t 1 A2l2e2l2t
A1e2l1t 1 A2e2l2t
(9)
In particular, kG(t) is higher at the beginning of the
IVGTT, when the fast component of glucose decay (l1)
plays an important role, and lower at the end of the
IVGTT, when only the slow component (l2) remains in
play.
Table 2. Cold and hot glucose effectiveness and insulin
sensitivity and basal plasma clearance rate for
2-compartment model and minimal models during
a standard and an insulin-modified IVGTT
Two-
Compartment
Model
Minimal Models
Standard
IVGTT
Insulin-
modified
IVGTT
Cold glucose effectiveness,
ml·kg21 ·min21 GE52.1 SGV54.1 SGV53.9
Hot glucose effectiveness,
ml·kg21 ·min21 GE*51.4 S*GV*52.2 S*GV*52.1
Cold insulin sensitivity,
31022 ml·kg21 ·min21
per µU/ml IS510.2 SIV55.8 SIV56.4
Hot insulin sensitivity,
31022 ml·kg21 ·min21
per µU/ml IS*57.9 S*IV*56.7 S*IV*57.7
Basal plasma clearance
rate, ml·kg21 ·min21 PCRb 52.5 S*GV*52.2 S*GV*52.1
See glossary for definition of terms.
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We compared the glucose decay curves and the
fractional decay rates of incremental glucose concentra-
tion predicted by the two-compartment and the mini-
mal models, using for the two-compartment model the
parameters of Table A1, and for the minimal model the
SG and V values reported in Table 2. Figure 6 shows the
glucose decay curves (A) and the fractional decay rates
of incremental glucose concentration (B) predicted by
the two models. The monoexponential decay curve
predicted by the minimal model and the two-exponen-
tial profile generated by the two-compartment model
are almost superimposable in the period of minutes
10–20 of the IVGTT but diverge thereafter, thus repro-
ducing closely the experimental observations by Quon
et al. (30). Of note is that the value of SG (0.021 min21)
lies between the values that kG takes on between 10
and 20 min [e.g., kG (minute 15) 5 0.023 min21]. These
results suggest that the validity of SG as descriptor of
the effect of glucose per se is confined to the initial
portion of the IVGTT. The local validity of SG is
probably related to the fact that, during an IVGTT with
a normal insulin response, SG estimation critically
depends on the glucose data collected in the early
portion of the IVGTT, when glucose concentration is
high over the baseline and insulin action, albeit increas-
ing, is still low (20). Because in that part of the test both
components of glucose decay are active, SG not only
reflects glucose effects on Rd and EGP but also the rapid
exchange of glucose between the accessible and the
nonaccessible compartments occurring in the early
part of the test.
Validation of SG
Validation of SG entails its comparison with the
analogous index measured with the glucose clamp
method, SG(clamp). In comparing SG with SG(clamp), one is
faced with the problem that such indexes have different
units: SG is expressed in min21, whereas SG(clamp) is
expressed in ml·kg21 ·min21. As previously suggested
in Ref. 17, to convert them to a common unit one has to
multiply SG by the minimal model volume of glucose
distribution, V. The correctness of this approach has
been formally demonstrated in Refs. 16 and 37. Of note
is that V emerges from the minimal model method and
can be individualized in each subject. In addition,
multiplication of SG by V parallels the approach used in
the validation studies of SI (10, 32).
The value of SGV found experimentally in the present
study (4.2 ml·kg21 ·min21) is much higher than the
value of SG(clamp) in normal subjects that can be found in
the literature (2.4 ml·kg21 ·min21 in Ref. 11). The same
trend is observed if the value of SGV obtained from our
Monte Carlo study is compared with the glucose effec-
tiveness index of the two-compartment model (see
Table 2). The reason for SGV being almost twice SG(clamp)
is that SG and SG(clamp) reflect different combinations of
the fast and slow components of glucose disappearance
at basal insulin, l1 and l2. We have shown that SG
reflects the values that kG takes on between 10 and 20
min. Thus, from Eq. 9, one has
SGV 5 3(A1l1e
2l1t0 1 A2l2e2l2t0)
(A1e2l1t0 1 A2e2l2t0) 4 V (10)
where t0 is ,15 min in subjects with a normal insulin
response. Equation 10 shows that SG is influenced by
both the fast and slow components of glucose disappear-
ance. To compare quantitatively SGV with SG(clamp), it is
useful to express SG as a function of l2 only. By
exploiting the fact that A1l1e2l1t0 < 2A2l2e2l2t0 and A2
e2l2t0 < 6A1e2l1t0 (the values of A1, A2, l1, and l2 reported
in Table D1), one has
SGV < 2.6l2V (11)
SG(clamp) is measured from a hyperglycemic glucose
clamp in which somatostatin is used to suppress the
endogenous insulin release, and the baseline insulin is
replaced by an exogenous insulin infusion (11). By
applying the formal definition of glucose effectiveness
reported in Eq. C1 to a hyperglycemic clamp at basal
insulin, one finds that SG(clamp) is defined as the ratio of
Fig. 6. Comparison between the two-compartment and the cold
minimal model predictions of glucose concentration (A) and frac-
tional decay rate of incremental glucose concentration (kG, B) during
an IVGTT at basal insulin. The value of SG estimated during an
IVGTT with a normal insulin response is close to the value of kG in
the initial portion of the test, approximately between 10 and 20 min.
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D(Rd 2 EGP) to the increment in plasma glucose
concentration at steady state. Given that in the hyper-
glycemic steady state the increment in the exogenous
glucose infusion rate, DGINF, equals D(Rd 2 EGP),
SG(clamp) is defined as follows
SG(clamp) 5
D(Rd 2 EGP)
Dg 0 i5ib 5
DGINF
Dg 0 i5ib (12)
Using the two-compartment model to describe the
glucose system during the clamp, one can express
SG(clamp) as a function of the parameters of the model
and, specifically, of the two components of glucose
disappearance at basal insulin (see derivation in APPEN-
DIX E)
SG(clamp) 5
1
1A1l1 1
A2
l2
2 (13)
It is easy to show that SG(clamp) is primarily deter-
mined by the slow component of glucose disappearance.
In fact, A2/l2 < 18A1/l1, and thus SG(clamp) < l2/A2.
Moreover, because 1/A2 approximates the total glucose
distribution volume VT (28), and VT < 1.3 V (see Tables
1 and A1), we can write
SG(clamp) < l2VT < 1.3l2V (14)
By comparing Eqs. 11 and 14, one realizes why SGV is
about twice SG(clamp). It is worth pointing out that SGV
and SG(clamp) are not only quantitatively, but also quali-
tatively different; SGV also reflects, in addition to
glucose effect on Rd and EGP [measured by SG(clamp)], the
exchange process taking place between the two glucose
compartments in the early part of the IVGTT. As a
consequence, the correlation between these two indexes
is unlikely to be strong, as suggested by the simulation
studies reported in Refs. 22 and 38.
Finegood and Tzur have compared SG with SG(clamp) in
dogs (24). To allow the comparison, the authors divided
SG(clamp) by the total volume of glucose distribution, VT,
taken from the literature (250 ml/kg). They found that
SG was higher than the ratio of SG(clamp) to VT and that
such indexes were poorly correlated. These findings
seem to support the notion that SG and SG(clamp) reflect
different aspects of glucose effect per se. However, as we
pointed out in Ref. 16, using VT to convert SG(clamp) to the
same units as SG is questionable because, as we have
discussed, the minimal model yields an index of glucose
effectiveness, SGV, that has the same units of SG(clamp)
and hinges on a volume that, in contrast to a mean
value of VT, can be individualized in each subject.
SG from an IVGTT at Basal Insulin
It is commonly believed that SG estimated from an
IVGTT at basal insulin is a reliable measure of glucose
effectiveness, because under such conditions glucose is
the only determinant of glucose decay. However, even
under these optimized conditions, the validity of SG is
uncertain because the minimal model forces a monoex-
ponential function to describe a two-exponential decay.
To determine whether SG estimated from an IVGTT at
basal insulin is a valid measure of glucose effectiveness,
it is useful to recognize that, under such experimental
conditions, a minimal model-independent index of glu-
cose effectiveness can be calculated directly from the
area under glucose decay. In fact in Ref. 4 we showed
that whenever insulin concentration is maintained at
the basal level and exogenous glucose forces glucose to
increase and return to the baseline, glucose effective-
ness at basal insulin, denoted as GEb in Ref. 4, is given
by the ratio between the administered amount of
glucose and the area under the curve of the glycemic
excursion above baseline [AUC(Dg)]. In the case of an
IVGTT at basal insulin, with the assumption that
glucose decay follows the two-exponential profile of Eq.
8, GEb is given by
GEb 5
D
AUC[Dg(t)]
5
1
1A1l1 1
A2
l2
2 (15)
Note that the expression of GEb in Eq. 15 coincides with
that of SG(clamp) in Eq. 13, in keeping with the analysis
carried out in Ref. 4 that ascertained the theoretical
equivalence of these two measurements of glucose
effectiveness. In that study (4), insulin was maintained
at the basal level and glucose excursion was similar to
that observed during a meal. Under those circum-
stances, SGV resulted in a value similar to GEb. It is
presently unknown whether this also holds for an
IVGTT at basal insulin, because during such an experi-
ment the glucose profile is less smooth than during a
meal, and the minimal model is unable to account for
the rapid fall of glucose immediately after the glucose
bolus. Nevertheless, some observations can be made.
We have seen previously that, during an IVGTT with a
normal insulin response, glucose decay reflects both
glucose effectiveness and insulin action, and SG is
mainly estimated from the glucose data collected in the
initial part of the IVGTT, when insulin action is still
low. During an IVGTT at basal insulin, insulin action is
null throughout the test, and glucose decay is governed
by glucose effectiveness only. As a result, all of the
glucose data between 10 min and the end of the test
contribute to SG estimation. Because the contribution of
the fast component of glucose disappearance, l1, soon
becomes negligible (e.g., after ,30 min in normal
subjects), and most of the glucose data are beyond that
point in time, SG will approach the slow component of
glucose disappearance, l2, and the minimal model
volume will approach the reciprocal of A2. Therefore,
SGV is approximated by
SGV <
l2
A2
(16)
Comparison of Eq. 16 with Eqs. 10 and 11 sheds some
light on the reasons why the value of SG obtained from
an IVGTT at basal insulin has been found to be lower
than that obtained from an insulin-modified IVGTT
(24): whereas the SG estimated during an insulin-
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modified IVGTT reflects both the fast and slow compo-
nents of glucose disappearance, the SG estimated from
an IVGTT at basal insulin reflects primarily the slow
component. Comparison of Eqs. 15 and 16 indicates
that, during an IVGTT at basal insulin, SGV will be
close to GEb if A2/l2 .. A1/l1. Because A2/l2 < 18A1/l1,
it is likely that SGV estimated from an IVGTT at basal
insulin is a reliable estimate of glucose effectiveness.
SG measured from an IVGTT at basal insulin has
been compared with SG(clamp) in dogs by Finegood and
Tzur (24). They found similar values for SG and SG(clamp)
but no correlation between them. Whereas the agree-
ment between the mean values of the two indexes is
consistent with the above analysis, the absence of
correlation between them is surprising. In fact, this
would mean that the minimal model is not able to
accurately assess glucose effectiveness, even when the
IVGTT is performed at basal insulin. As pointed out in
Ref. 16, one possible explanation for this finding is the
relatively narrow range of glucose effectiveness ob-
served in the group of dogs examined in that study.
Another possible explanation is related to the fact that,
at the end of the IVGTT studies carried out at basal
insulin, glucose concentration was below the pretest
level and still declining. This outcome may be due to the
difficulty of obtaining a stable baseline for glucose
concentration with the combined somatostatin, gluca-
gon, and insulin infusion protocol. Alternatively, it
could be the symptom of an inaccurate description of
EGP in the minimal model. In fact, the model assumes
that any change in glucose concentration is accompa-
nied by a proportional and opposite change in EGP. The
time course of EGP during an IVGTT at basal insulin is
thus expected to mirror that of glucose concentration.
However, the finding that at the end of the IVGTT
glucose concentration was below the pretest level and
still declining suggests that EGP was still inhibited at
that time, implying that the minimal model description
is not correct. This model inadequacy may have affected
the accuracy of SG and worsened its concordance with
SG(clamp).
COLD INSULIN SENSITIVITY
Effects of Monocompartmental Undermodeling on SI
The monocompartmental approximation also influ-
ences the minimal model estimates of insulin action
and sensitivity. As shown in Ref. 18, because the model
has to compensate for SG overestimation and fit the
glucose data, insulin action is underestimated approxi-
mately until glucose returns to the baseline and is
overestimated thereafter. This bias also affects SI,
because this parameter can be expressed as the ratio
between the AUCs of insulin action and insulin concen-
tration above basal level (18). Here we build on that
paper and analyze the bias affecting the minimal model
insulin action and SI by comparing them with the
insulin action and sensitivity of the two-compartment
model. In carrying out this comparison, one must bear
in mind that the cold model insulin action, x(t), repre-
sents the sum of the insulin effects on glucose uptake
and production. In the two-compartment model, xd(t) is
insulin action on glucose uptake, and xp(t) is insulin
action on production. Thus X(t) 5 xp(t)1xd(t) represents
exactly what x(t) represents for the minimal model. The
profiles of X(t) and x(t) during a standard IVGTT are
compared in Fig. 7A. X(t) was generated using the
two-compartment model parameters reported in Table
A1; x(t) was generated using the mean parameters SI
and p2 estimated with the Monte Carlo simulation
described in APPENDIX B (SI 5 2.9 3 1024 min21 ·µU21 ·ml
and p2 5 0.027 min21). It can be seen that the minimal
model markedly underestimates insulin action during
the first half of the test and slightly overestimates it
thereafter. It must be recognized, however, that this
bias originates not only from the different model order
(one vs. two pools) but also from the different location of
insulin action on glucose uptake (accessible vs. nonac-
cessible pool). To single out the effect of monocompart-
mental undermodeling per se, we calculated in APPEN-
DIX F the effect that xd(t) produces on the accessible pool
of the two-compartment model. We termed this effect as
x˜(t). X˜(t) 5 xp(t) 1 x˜d(t) is therefore the ‘‘accessible-pool
equivalent’’ insulin action of the two-compartment model
that produces the same effect as X on plasma glucose
concentration (i.e., the accessible-pool Rd remains the
same). X˜(t) is shown in Fig. 7B plotted against the
insulin action of the minimal model. Qualitatively
speaking, X˜(t) is a delayed and blunted version of X(t).
The difference Dx(t) 5 X˜(t) 2 x(t) represents the effect
of monocompartmental undermodeling on the minimal
model insulin action. Dx(t) can be analyzed theoretically
by assuming that the minimal model fit of IVGTT
glucose concentration is perfect. In this case an analytic
expression for Dx(t) can be derived (details in APPENDIX
F) that helps to single out the determinants of the bias
Dx(t) 5 X˜(t) 2 x(t)
5 2 31GEV1 2 SG2
Dg(t)
g(t)
1
g
(k22)2
g˙˜2(t)
g(t) 4
(17)
where GE/V1 is the fractional glucose effectiveness of
the two-compartment model, g 5 k21k12 and k22 5
(k021k12), and g˜2(t) is glucose concentration in the
nonaccessible pool when insulin-dependent glucose re-
moval occurs in the accessible pool.
The question arises as to what extent the analytic
expression of Dx(t) derived under the assumption of
perfect minimal model fit agrees with the profile of Dx(t)
calculated by subtracting the profiles of x(t) and dis-
played in Fig. 7B [note that x(t) has been estimated
from simulated, but realistic, IVGTT data and thus
reflects a realistic, but not perfect, minimal model fit].
The two profiles of Dx(t) are compared in Fig. 7C. They
agree closely, indicating that Eq. 17 provides a good
description of this difference. The only discrepancy
occurs in the initial portion of the IVGTT. This is not
surprising, because the analytic Dx(t) is calculated in
the hypothesis of perfect minimal model fit. In contrast,
it is well-known that the minimal model is unable to fit
the initial rapid decay of glucose and that the glucose
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data collected in the first 10 min of the test are not used
in model identification. Thus from 10 min on we can use
with confidence Eq. 17 to gain insight into the sources
of the bias affecting the minimal model insulin action.
It can be seen that Dx depends not only on SG overesti-
mation of the fractional glucose effectiveness of the
two-compartment model (GE/V1 5 0.0133 min21) but
also on the dynamics of glucose in the second glucose
compartment. The first component of Dx(t), i.e., the bias
affecting the estimate of glucose effectiveness (SG 2
GE/V1), is weighted by the term Dg(t)/g(t). Such a
function of time has a shape resembling that of plasma
glucose decay and changes its sign when glucose exhib-
its an undershoot below its basal level. The second
component, depending on glucose dynamics in the
nonaccessible pool, is the major determinant of Dx(t). In
fact, Dx(t) becomes positive at 20 min, i.e., approxi-
mately when g˜2(t) achieves its maximum, and returns
negative at 140 min, just when g˜2(t) achieves its
minimum. This implies that the bias affecting insulin
action cannot be obviated completely by forcing SG to
assume a more accurate value.
The bias of insulin action obviously affects SI. The
difference between the fractional insulin sensitivity of
the two-compartment model (IS/V1) and SI is given by
Eq. F7 in APPENDIX F
DSI 5
IS
V1
2 SI <
AUC[Dx(t)]
AUC[i(t) 2 ib]
(18)
Equation 18 indicates that the bias of SI depends on the
whole time course of insulin action, so that compensa-
tions may occur between portions of the IVGTT when Dx
is positive and portions when Dx is negative. Thus
overestimation of SG does not necessarily imply that SI
is underestimated, as recently pointed out (18, 24).
However, because in our simulation study the AUC of
underestimation is much greater than the AUC of
overestimation, SI underestimates the fractional insu-
lin sensitivity of the two-compartment model by 55%
(see Tables 1, 2, and A1). When SI is multiplied by the
minimal model volume, V, to allow comparison with IS
(10, 32), underestimation reduces to 43% because V is
higher than V1. Another observation is that the bias
affecting SI may be scarcely influenced by the value
assumed by SG, especially during a modified IVGTT in
normal subjects. In fact, under such experimental
conditions and in such a group of people, the integral of
Dg(t)/g(t) in Eq. 17 is very small, because the little but
prolonged undershoot of glucose below its basal level
due to the second insulin peak at 20 min gives rise to a
negative AUC that balances the positive area associ-
ated with the rapid decline of glucose during the 1st h of
the test. Because the integral of Dg(t)/g(t) measures the
effect that a unit change in SG produces on SI, it is likely
that the sensitivity of SI to errors in SG is small.
One may wonder whether the underestimation of SI
may be mitigated by modifying the insulin profile
during the IVGTT. This could happen, because insulin
dynamics during the IVGTT affects both the numerator
Fig. 7. A: comparison between insulin action of the two-compartment
and the cold minimal models during a standard IVGTT. B: insulin
action of the two-compartment model, which, if applied to the
accessible pool, would produce the same effect on glucose con-
centration as the one taking place in the nonaccessible pool. This
‘‘accessible-pool equivalent’’ profile of the two-compartment insulin
action is contrasted with the cold minimal model insulin action.
C: difference between insulin action profiles of B is the effect of
monocompartmental undermodeling on cold minimal model insulin
action. This difference is shown against its analytically predicted
time course.
E1180 MINIMAL MODEL INDEXES
 o
n
 O
ctober 13, 2011
ajpendo.physiology.org
D
ow
nloaded from
 
and the denominator of Eq. 18. The impact on the
denominator is obvious; that on the numerator is due to
the fact that the insulin profile influences the time
course of glucose concentration in both the glucose
pools, thus producing an effect on AUC[Dx(t)] as well
(see Eq. 17). The Monte Carlo simulation results of
Table 1 suggest that the modified IVGTT slightly
mitigates the bias of SI. In fact, SIV underestimation
with respect to IS reduces to 37%. Thus the modified
IVGTT favors not only a greater precision (40) but also
a greater accuracy of SI. In our simulation the improve-
ment of SI accuracy was primarily due to the increment
in AUC[i(t) 2 ib]. In fact, although the added burst of
insulin steepened the glucose curve, thus making Dx(t)
less sluggish than during the standard IVGTT,
AUC[Dx(t)] did not change much.
One final remark concerns the effect of monocompart-
mental undermodeling on the estimation of SI in non-
insulin-dependent diabetes mellitus (NIDDM). Many
reports have shown that SI estimated from an insulin-
modified IVGTT in NIDDM patients is often imprecise
and poorly correlated with the index calculated with
the glucose clamp (3, 32). These problems can be
interpreted, at least in part, in the light of the above-
mentioned effects of single-compartment undermodel-
ing on insulin action and SI. The true insulin action in
NIDDM patients is presumably very low because this
group is markedly resistant to insulin. The error due to
monocompartmental undermodeling can cause the mini-
mal model insulin action to become so low and slow as
to degrade the precision of SI. In addition, even when SI
can be precisely estimated, its value will be markedly
underestimated. Underestimation of SI will further
narrow the range of the minimal model estimates of
insulin sensitivity in this group, thus worsening the
correlation with the clamp-based measure of insulin
sensitivity.
Validation of SI
Validation of SI entails its comparison with SI(clamp),
i.e., the glucose clamp measure of insulin sensitivity. By
applying the formal definition of insulin sensitivity
reported in Eq. C3 to a euglycemic, hyperinsulinemic
clamp, one finds that SI(clamp) is the steady-state ratio of
D(Rd 2 EGP) to the increment in plasma insulin
concentration, normalized to the ambient plasma glu-
cose concentration at which the clamp is performed.
Because in the hyperinsulinemic steady state the incre-
ment in the exogenous glucose infusion rate equals
D(Rd 2 EGP), SI(clamp) is defined as follows (7, 10, 32)
SI(clamp) 5
D(Rd 2 EGP)
gDi 0g5gb 5
DGINF
gDi 0g5gb (19)
To compare SI with SI(clamp), SI is usually multiplied by
the glucose distribution volume of the minimal model,
V (10, 32). SIV and SI(clamp) are well correlated, espe-
cially in normotolerant subjects, when the IVGTT is
modified with the injection of either tolbutamide or
insulin (5, 10, 32). Are they also equivalent measures of
insulin sensitivity, i.e., is their regression line indistin-
guishable from the unity line (slope 5 1, intercept 5 0)?
Equivalence between SIV and SI(clamp) is controversial in
the literature.
In the study by Beard et al. (5) in normotolerant
subjects, SI was measured with the tolbutamide-
modified IVGTT, and SI(clamp) was measured with sequen-
tial low-insulin-dose euglycemic clamps, bringing insu-
lin to plateaus of 21 and 35 µU/ml. A strong correlation
between SI and SI(clamp) was found (r 5 0.84). However, if
one calculates the product SIV [using for V a typical
value of 170 ml/kg (10, 17)], one finds that SIV was
approximately 60% lower than SI(clamp) (0.11 vs. 0.29
ml·kg21 ·min21 ·µU21 ·ml).
Bergman et al. (10) compared SIV and SI(clamp) in a
group of normotolerant and obese subjects. SIV was
measured with the tolbutamide-modified IVGTT, and
SI(clamp) was measured with low- and high-insulin-dose
euglycemic clamps carried out on different days. Insu-
lin levels were 41 and 114 µU/ml, thus higher than in
Ref. 5. Although SIV was slightly lower than SI(clamp) in
all subjects but one, SIV was equivalent to SI(clamp)
(0.046 vs. 0.052 dl ·min21 ·µU21 ·ml, respectively).
Saad et al. (32) compared SIV with SI(clamp) in normal
controls, subjects with impaired glucose tolerance (IGT),
and patients with NIDDM. SI was measured with the
insulin-modified IVGTT (insulin bolus of 0.03 U/kg at
20 min), while SI(clamp) was measured with a single
high-insulin-dose euglycemic clamp, bringing insulin
levels to 83 µU/ml. Although results show SIV and
SI(clamp) well correlated in normal and IGT subjects, SIV
was .50% lower than SI(clamp).
More recently, Saad et al. (33) measured SIV in
normal controls with both the tolbutamide- and the
insulin-modified IVGTT, while SI(clamp) was measured
with the same insulin infusion used in Ref. 32. SIV from
the tolbutamide-modified IVGTT was only 13% lower
than SI(clamp) (0.045 vs. 0.054 dl · min21 · µU21 · ml),
whereas SIV from the insulin-modified IVGTT (0.030
dl ·min21 ·µU21 ·ml) was 44% lower than SI(clamp).
Comparison of the results obtained in the above-
mentioned studies suggests that equivalence of SIV and
SI(clamp) depends on how the IVGTT and the clamp are
performed. For instance, the marked difference be-
tween SIV and SI(clamp) that is present when either SIV is
estimated from an insulin-modified IVGTT (32) or
SI(clamp) is estimated from low-dose insulin clamps (5)
vanishes when SIV is estimated from a tolbutamide-
boosted IVGTT and SI(clamp) is derived from high-dose
insulin clamps (10, 33). To understand the reasons for
this protocol dependency, it is useful to examine the
hypotheses governing the assessment of SI and SI(clamp).
For SI to be equivalent to SI(clamp), a number of condi-
tions must be met, the most important of which are that
1) the minimal model single-pool description of glucose
kinetics is adequate; 2) insulin effect on the aggrega-
tion of Rd and EGP increases linearly with insulin
concentration across the insulin range experienced
during the IVGTT and the clamp; 3) insulin sensitivity
is independent from the route of insulin delivery (portal
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vs. peripheral); and 4) tolbutamide has no effects per se
on glucose metabolism. We have already shown that
monocompartmental undermodeling leads to SI under-
estimation. We now analyze how the other factors can
influence the estimation of SI and SI(clamp).
Linearity of insulin effect. Both SI and SI(clamp) mea-
sure the ability of insulin not only to increase Rd but
also to inhibit EGP. Therefore, both such aspects of
insulin action are important in determining overall
insulin sensitivity. In glucose clamp studies, insulin
levels are brought to ,40 and 100 µU/ml during either
low- or high-dose insulin clamps. Whereas the steady-
state relationship between Rd and insulin concentra-
tion is approximately linear in the physiological range
(10–100 µU/ml) (7), the relationship between EGP and
insulin concentration is highly nonlinear in the same
range, because EGP achieves nearly complete suppres-
sion at insulin levels of ,40 µU/ml (26), so that any
further increment in insulin concentration is not accom-
panied by a proportional decrement in EGP. Evidence
that the nonlinearity of the relationship between insu-
lin concentration and EGP suppression is likely to
affect the measurement of SI(clamp) can be derived from
the study of Katz et al. (26). The data reported in that
dose-response study allow calculation of SI(clamp) at
three insulin levels: 25, 43, and 123 µU/ml. SI(clamp)
shows results of 0.19, 0.21, and 0.10 ml·kg21 ·min21 ·
µU21·ml, respectively. These values indicate that SI(clamp)
is independent of the insulin level until EGP reaches
nearly complete suppression at ,40 µU/ml. As the
insulin level increases beyond that point, any further
increase in insulin action will depend solely on an
increase in Rd. That SI(clamp) depends on the insulin level
at which the clamp is performed can also be inferred by
comparing the values of SI(clamp) in normal subjects
obtained in the studies by Beard et al. (5) and Saad et
al. (32). SI(clamp) was 0.29 ml·kg21 ·min21 ·µU21 ·ml in
Ref. 5, in which insulin levels were 21 and 35 µU/ml,
but 0.10 ml·kg21 ·min21 ·µU21 ·ml in Ref. 32, in which
insulin level was 83 µU/ml. All in all, these data
suggest that when SI(clamp) is derived from a high-dose
insulin clamp, it will tend to underestimate insulin
effect on EGP.
During an IVGTT, because of the dynamic nature of
the test, what really matters is the insulin level at-
tained in the remote insulin compartment from which
insulin action is exerted. During a standard or a
tolbutamide-boosted IVGTT, plasma insulin levels
rarely exceed 200 µU/ml, and insulin action is likely to
remain within the quasi-linear range. The risk of
entering into the nonlinear range of insulin action
increases during an insulin-modified IVGTT in which
peak insulin levels as high as 400–600 µU/ml are
elicited by a bolus or a short infusion of exogenous
insulin. As a matter of fact, a recent report by Vicini et
al. (39) suggests that saturation of insulin effect on
EGP is likely to take place during an insulin-modified
IVGTT. In that study (39), the time course of EGP
during an insulin-modified IVGTT was accurately as-
sessed by using the tracer-to-tracee (specific activity)
clamp. EGP achieved almost complete suppression at
20 min and remained suppressed for another 20 min
after the exogenous insulin administration. We specu-
late that, because between 20 and 40 min the high
insulin levels due to the exogenous insulin injection
cannot produce any further inhibition in EGP, insulin
effect on EGP is underestimated in that interval. It
seems, however, that this transient saturation of insu-
lin effect on EGP (and possibly on Rd) is unable to
influence SI appreciably (comprising both the effects of
insulin on Rd and EGP). In fact, recent results provided
by Saad et al. (34), contradicting a previous report by
Prigeon et al. (29), indicate that the estimate of SI is not
appreciably influenced by the peak insulin level
achieved during an insulin-modified IVGTT in which
insulin is administered either as a bolus or as an
equidose short infusion.
Portal vs. peripheral route of insulin delivery. In
comparing SI with SI(clamp), we assume that the periph-
eral and portal routes of insulin delivery are equally
effective in inhibiting EGP. Unlike SI(clamp), which mea-
sures insulin ability to suppress EGP and elevate Rd in
response to peripheral insulin delivery, SI is estimated
from insulin and glucose profiles in response to either
portally delivered insulin (during a standard or a
tolbutamide-modified IVGTT) or to a mixture of por-
tally and peripherally appearing insulin (during an
insulin-modified IVGTT). Recently, Steil et al. (35)
studied the contribution of portal insulin to the assess-
ment of SI by performing paired insulin-modified
IVGTTs in dogs in which insulin was infused either
portally or peripherally with matched peripheral insu-
lin levels. They found that portal insulin delivery does
not significantly affect insulin’s ability to normalize
plasma glucose after the glucose bolus and that the
route of insulin delivery does not appreciably affect SI.
Effects of tolbutamide. Saad and colleagues (33, 34)
have shown that the tolbutamide-boosted protocol pro-
vides higher SI estimates than the insulin-modified
protocol, regardless of the method of insulin administra-
tion (bolus or 5- or 10-min infusion). The higher SI
values from the tolbutamide protocol cannot be ex-
plained by differences in peripheral insulinemia, be-
cause giving insulin as a 10-min infusion results in
peripheral insulin levels similar to those measured
after tolbutamide (34). In addition, the aforementioned
study by Steil et al. (35) seems to rule out the possibility
that this difference is due to the effect of higher portal
concentrations seen after tolbutamide but not insulin
injection. Saad et al. (34) hypothesized that tolbutamide-
induced proinsulin release during the IVGTT could
play a role in elevating the estimates of SI with the
tolbutamide protocol with respect to those obtained
with the insulin protocol. Alternatively, differences in
SI between tolbutamide- and insulin-modified IVGTTs
could be due to some extrapancreatic effect of tolbuta-
mide, as recently suggested (31). Whatever the case,
the injection of tolbutamide contributes to elevate SI
with respect to SI(clamp).
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HOT GLUCOSE EFFECTIVENESS
Effect of Monocompartmental Undermodeling on S*G
To study the effect of the monocompartmental ap-
proximation on S*G, we will use the same rationale
previously used for SG, i.e., we will first analyze the
decay of hot glucose during a hot IVGTT in which
insulin is maintained at the basal level. The minimal
model predicts that the decay of hot glucose concentra-
tion is monoexponential, with S*G as rate constant
g*(t) 5
D*
V*
e2S*Gt (20)
Thus the fractional decay rate of the tracer will be
constant and equal to S*G
k*G(t) 5 2 g˙*(t)/g*(t) 5 S*G (21)
In contrast, the two-compartment model predicts
that the hot glucose decay is described by an almost
two-exponential profile (APPENDIX D)
g*(t) 5 D*(A*1e2l*1t 1 A*2e2l*2t) 1 a(t) (22)
where l*1 and l*2 (l*1 . l*2, min21) are the fast and slow
rate constants of glucose kinetics in the basal state,
respectively, and the term a(t) accounts for the effect of
hyperglycemia on glucose clearance. The corresponding
fractional decay rate is no longer constant, and its time
course is shown in Fig. 8. k*G is high at the beginning of
the IVGTT, when the fast component of glucose kinetics
plays a relevant role, shows a rapid decline followed by
a slight undershoot due to a(t), and then increases
slowly, getting closer and closer to l*2.
During a hot IVGTT, S*G is primarily estimated in the
final portion of the test, when both insulin and
glucose concentrations have almost returned to the
baseline. At that point in time, both the contribution of
the fast component of glucose kinetics and the inhibi-
tory effect of hyperglycemia on glucose clearance have
become negligible, and hot glucose decay is governed
only by the slow component of glucose kinetics, l*2.
Thus, in the final part of the IVGTT, a single-pool
description of glucose kinetics is adequate to describe
hot glucose decay, and S*G approximates l*2. As a matter
of fact, by comparing Tables 1 and D1, one can see that
the value of S*G estimated with the Monte Carlo simula-
tion is close to l*2 (S*G 5 0.0102 and 0.0098 min21 from
the standard and modified IVGTT, respectively, and l*2 5
0.0093 min21). This agreement suggests that the do-
main of validity of S*G is confined to the final portion of
the IVGTT. To clarify the physiological meaning of S*G,
it is of interest to recall that the basal plasma clearance
rate of glucose, PCRb, is the inverse of the area under
the hot glucose impulse response at basal insulin. The
area can be expressed as a function of the eigenvalues
of the two-exponential impulse response, as follows (13)
PCRb 5
1
1A*1l*1 1
A*2
l*22 (23)
Given that A*2/l*2 , 14A*1/l*1 (see Table D1), Eq. 23
reduces to
PCRb < l*2/A*2 (24)
Because S*G approximates l*2 and 1/A*2 approximates VT
(28), one has
S*G <
PCRb
VT
(25)
Therefore, S*G measures the ratio of glucose clearance
and total distribution volume, i.e., basal fractional
glucose clearance rate. In fact, if the S*G found experi-
mentally in this study (0.0082 min21) is multiplied by a
total volume of glucose distribution taken from the
literature (260 ml/kg), one obtains 2.03 ml·kg21 ·min21,
which agrees with the values of the basal plasma
clearance rate found in the literature. The same trend
is observed if S*G estimated from the Monte Carlo study
is compared with the ratio between the plasma clear-
ance rate and the total distribution volume of the
two-compartment model (S*G 5 0.0102 and 0.0098
min21 from the standard and modified IVGTT, respec-
tively, and PCR/VT 5 0.0096 min21). The reliability of
S*G as a descriptor of the basal fractional glucose
clearance has been assessed in dogs by comparing S*G
with the basal glucose clearance rate independently
measured by the arteriovenous technique (19).
Validation of S*G
In the hot minimal model, it is assumed that glucose
uptake is proportional to glucose concentration. As a
result, glucose clearance and glucose effectiveness on
glucose disposal coincide in the model (see Table C1).
Fig. 8. Fractional decay rate of hot glucose (k*G) during a hot IVGTT
at basal insulin. The value of S*G estimated during a hot IVGTT with a
normal insulin response is close to the value of k*G in the final portion
of the test.
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However, it is a well-established notion that glucose
uptake is not proportional to glucose concentration and
that, in the range of interest, the Rd vs. g relationship
can be approximated by a line that has a nonzero
intercept with the Rd axis (6, 11, 12, 36). As a conse-
quence, glucose clearance and glucose effectiveness on
glucose disposal do not coincide. In this section we
clarify the relationship existing between S*G and the
clamp estimate of glucose effectiveness on glucose
disposal, SG,d(clamp). SG,d(clamp) is measured from hypergly-
cemic glucose clamp studies at basal insulin in which
exogenous glucose is used to progressively increase
glucose concentration, g, at various steady state levels,
and a tracer is concurrently infused to measure Rd (12).
By applying the definition of hot glucose effectiveness
reported in Eq. C2 to a hyperglycemic clamp at basal
insulin, one finds that SG,d(clamp) is the slope of the linear
relationship between the Rd and g
Rd 5 SG,d(clamp)g 1 Rd,0 (26)
where Rd,0 is the nonzero intercept. Recalling that S*G
measures fractional basal glucose clearance (Eq. 25),
and using the definition of basal glucose clearance (Eq.
C5), one has
S*GVT < PCRb 5
Rdb
gb
(27)
Combining Eqs. 26 and 27 yields
S*GVT < SG,d(clamp) 1
Rd,0
gb
(28)
Equation 28 confirms that S*G does not coincide with
SG,d(clamp) (apart from the volume factor) because of the
presence of the nonzero intercept Rd,0. Thus S*G cannot
be used as an index of glucose effectiveness unless the
presence of Rd,0 is explicitly taken into account in the
hot minimal model. In a recent paper investigating
glucose effectiveness during a meal-like study (4), the
hot minimal model was modified to allow for the
presence of Rd,0. Both S*G and Rd,0 were estimated from
the data, because the basal plasma clearance rate was
available in each subject, thanks to a pretest tracer
equilibration experiment. It is worth noting that this
pretest tracer experiment is not commonly performed
before the IVGTT, and this makes the simultaneous
estimation of S*G and Rd,0 from hot IVGTT data ex-
tremely difficult (17).
SG vs. S*G
The analysis of the relationships SG vs. SG(clamp) and
S*G vs. SG,d(clamp) suggests a possible explanation for the
lack of correlation between SG and S*G found in this
study. One would expect to find a good correlation
between SG and S*G because glucose clamp studies have
shown that glucose effectiveness on Rd is the major
determinant (,2/3) of overall glucose effectiveness,
with the remainder accounted for by the effect of
glucose to inhibit EGP (11). However, as we have
shown, SG and S*G are not equivalent to SG(clamp) and
SG,d(clamp), respectively. In fact, SG and SG(clamp) measure
related, but not identical, physiological processes, be-
cause SG, at variance with SG(clamp), is markedly influ-
enced by the rapid exchange of glucose that takes place
between the accessible and nonaccessible compart-
ments after the glucose bolus. Likewise, S*G measures
the fractional basal glucose clearance rate, but not
glucose effectiveness on Rd, because the hot model does
not account for the the inhibitory effect of glucose on its
own clearance.
HOT INSULIN SENSITIVITY
Effects of Monocompartmental Undermodeling on S*I
The estimation of S*I suffers from problems that, to
some extent, are opposite to those affecting SI. Because
S*G approximates the slow time constant of glucose
kinetics at basal insulin, the minimal model tends to
underestimate the rate of hot glucose decay per se
(independently of insulin) during the early portion of
the IVGTT, when the fast component of glucose kinetics
plays an important role. To compensate for this under-
estimation and to fit hot glucose data, the hot minimal
model insulin action is probably overestimated in the
initial part of the IVGTT. To verify this hypothesis, we
compared the insulin action on glucose disposal of the
two-compartment model, xd(t), with the hot minimal
model insulin action, x*(t) (Fig. 9A). The latter profile is
generated using the mean parameters S*I and p*2 esti-
mated by Monte Carlo simulation (S*I 5 3.2 3 1024
dl ·kg21 ·min21 ·µU21 ·ml and p*2 5 0.069 min21). As
argued in comments concerning cold insulin action, the
difference between these profiles does not reflect only
the different model order but also the different location
of insulin action in the two models. Thus, to single out
the effect of monocompartmental undermodeling per
se, we calculated in APPENDIX F the effect that xd(t)
produces on hot glucose concentration in the accessible
pool of the two-compartment model. This ‘‘accessible-
pool equivalent’’ profile of insulin action on glucose
disposal, x˜*d(t) (the asterisk denotes that it is derived
from tracer data), is compared with x*(t) in Fig. 9B.
One can see that the hot minimal model overestimates
insulin action until ,30 min and underestimates it
thereafter. The difference D*x 5 x˜*d 2 x* represents the
effect of monocompartmental undermodeling on the
insulin action of the hot minimal model. D*x can be given
the following analytic expression in the hypothesis that
the minimal model fit of hot glucose data is perfect
(APPENDIX F)
D*x(t) 5 x˜*d(t) 2 x*(t)
5 2 31GE*V1 2 S*G2 1
g
(k22)2
g˙˜*2(t)
g*(t)
1
Rd,0
V1g(t)4
(29)
where GE*/V1 is the fractional hot glucose effectiveness
of the two-compartment model; g˜*2 is hot glucose concen-
tration in the nonaccessible glucose pool when insulin-
dependent glucose removal occurs in the accessible
pool. D*x obtained from Eq. 29 is plotted in Fig. 9C
against the profile of D*x obtained from the difference
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between the profiles of x˜*d and x* displayed in Fig. 9B.
The two profiles agree closely except in the initial part
of the test, because the hot model is unable to fit the
initial rapid decay of hot glucose that follows the
glucose bolus. The structure of D*x resembles that of Dx
(Eq. 17). In fact, D*x depends on the difference between
the fractional glucose effectiveness of the two models
and on the dynamics of hot glucose concentration in the
nonaccessible pool; D*x also shows a term proportional to
Rd,0 that accounts for the fact that the hot minimal
model does not comprise a description of the inhibitory
effect of glucose on its own clearance.
The bias affecting S*I can be calculated as previously
done for SI
DS*I 5
IS*
VI
2 S*I <
AUC[D*x(t)]
AUC[i(t) 2 ib]
(30)
As for SI, the bias of SI depends on the whole time
course of insulin action, so that compensations may
occur between portions of the IVGTT when D*x is
positive and others when D*x is negative. It can be
calculated from Table 1 that S*I underestimates the
fractional hot insulin sensitivity of the two-compart-
ment model by 36%. When S*I is multiplied by the hot
minimal model volume, V*, to allow comparison with
IS*, underestimation reduces to ,15%. S*I underesti-
mation can be mitigated by enhancing the insulin
signal during the hot IVGTT. In fact, the Monte Carlo
simulation results of Table 1 indicate that S*IV* calcu-
lated from an insulin-modified IVGTT is almost identi-
cal to IS*.
One final remark concerns the ability of the hot
minimal model to overcome the problems encountered
with the cold minimal model in assessing insulin
sensitivity in NIDDM patients. In Ref. 3 we have shown
and explained why S*I can be precisely estimated even
in those NIDDM patients in whom SI cannot be esti-
mated or is estimated with poor precision.
Validation of S*I
S*I has not yet been validated against the analogous
clamp-based index SI,d(clamp). However, S*I has been
compared with the insulin sensitivity index yielded by
the two-compartment minimal model developed in Ref.
14. Such a model, which explicitly accounts for glucose
inhibition of glucose clearance, yields an insulin sensi-
tivity index, SI
2*, that is expressed in the same units as
SI,d(clamp)(37). S*IV* has been found to be similar and well
correlated to SI
2* (37). Although this agreement does not
prove S*I accuracy, it suggests that monocompartmental
undermodeling and the inadequate description of glu-
cose effect on its own clearance do not bias S*IV*
appreciably, presumably because of a reasonably good
compensation between the initial overestimation and
the subsequent underestimation of hot insulin action.
SI vs. S*I
The error analysis of cold and hot insulin action and
sensitivity explains the paradoxical finding SI , S*I. In
fact, whereas the underestimation affecting SI is large,
that affecting S*I is modest.
Also, the unexpected time lag between cold and hot
insulin action may be due, at least in part, to a different
effect of the monocompartmental approximation on the
Fig. 9. A: comparison between insulin action on glucose disposal of
two-compartment model and insulin action of hot minimal model
during a standard hot IVGTT. B: insulin action of two-compartment
model, which, if applied to the accessible pool, would produce the
same effect on hot glucose concentration as the one taking place in the
nonaccessible pool. This ‘‘accessible-pool equivalent’’ profile of two-
compartment insulin action is contrasted with the hot minimal model
insulin action. C: difference between insulin action profiles of B is the
effect of monocompartmental undermodeling on hot minimal model
insulin action. This difference is shown against its analytically
predicted time course.
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insulin action of the two models. By comparing Figs. 7B
and 9B, one can see that x is delayed with respect to the
insulin action of the two-compartment model, whereas
x* is anticipated. This would provide a possible explana-
tion of why parameter p2 of the cold minimal model,
which governs the speed of rise and decay of x, is
systematically lower than the analogous hot parame-
ter p*2.
CONCLUSIONS
The findings of the present paper can be summarized
as follows.
SG reflects the rate of glucose decay per se, indepen-
dent of increased insulin, in the initial portion of the
IVGTT, approximately between 10 and 20 min. It
reflects not only the ability of glucose to promote Rd and
inhibit EGP but also the rapid exchange of glucose that
occurs between the two glucose compartments after the
glucose bolus. Because the latter component of SG is
nonnegligible, as suggested by the simulation studies
in Refs. 22 and 38, the reliability of SG as descriptor of
glucose effectiveness is uncertain.
The effects of single-compartment undermodeling on
SG determine undesired compensations on cold insulin
action and SI. Insulin action is markedly underesti-
mated for a considerable portion of the IVGTT. SI,
which is proportional to the integral of insulin action, is
also markedly underestimated. Although the SI esti-
mated from an insulin-modified or a tolbutamide-
boosted IVGTT strongly correlates with SI(clamp), it must
be pointed out that both SI and SI(clamp) are protocol
dependent and, in general, are not equivalent. In fact,
besides the description of glucose kinetics (one vs. two
compartments), other factors like nonlinearity of insu-
lin action on EGP and effects of tolbutamide can
influence their estimation.
S*G cannot be used as a descriptor of glucose effective-
ness on glucose disposal unless an explicit description
of the inhibitory effect of glucose on its own clearance is
included in the hot model. Nevertheless, S*G has a
clear-cut physiological interpretation, because it mea-
sures basal fractional glucose clearance.
Hot insulin action is influenced by monocompartmen-
tal undermodeling as well as by the hot model assump-
tion that glucose has no effect on its own clearance. Hot
insulin action is markedly overestimated in the initial
portion of the IVGTT and is underestimated thereafter.
S*I, which is proportional to the integral of hot insulin
action, is only slightly underestimated, thus giving
results more accurate than SI. Although S*I has not yet
been compared with the analogous clamp-based esti-
mate of peripheral insulin sensitivity, it is well corre-
lated to the estimate of insulin sensitivity provided by a
physiological two-compartment minimal model (37).
The cold indexes SG and SI, but not the hot indexes S*G
and S*I, suffer from an additional problem: their accu-
racy depends not only on the description of glucose
kinetics (one vs. two compartments) but also on the
reliability of the description of glucose and insulin
control on EGP embodied in the cold model. This issue
has not been examined in this article. Recently, the
tracer-to-tracee (specific activity) clamp has been used
to estimate EGP in a model-independent fashion dur-
ing an IVGTT (39). The resulting profile is not in
agreement with the assumptions of the minimal model.
However, it is difficult to single out the extent to which
SG and SI are affected by this problem until a more
reliable description of glucose and insulin control on
EGP becomes available.
A two-compartment structure is the obvious way to
go to anticipate and prevent monocompartmental under-
modeling. As far as the hot minimal model is concerned,
a two-compartment hot minimal model has been pro-
posed that not only allows estimation of EGP by
deconvolution (14, 39) but also yields metabolic indexes
of glucose effectiveness, insulin sensitivity, and glucose
clearance (37). The relationships between the indexes
provided by the two-compartment and the single-
compartment hot minimal models have been thor-
oughly examined in Ref. 37. The formulation of a cold
two-compartment minimal model is far more difficult,
because one is faced with a priori identifiability prob-
lems. Preliminary results (15) indicate that a two-
compartment model can be resolved from cold IVGTT
data if the available knowledge on the exchange kinet-
ics between the accessible and nonaccessible glucose
pools is incorporated in the model by a Bayesian
approach. A possible alternative to mitigate the impact
of monocompartmental undermodeling is to design
experimental protocols that, at variance with the
IVGTT, are characterized by more physiological glucose
and insulin profiles, i.e., they are smoother than those
observed during the IVGTT. This strategy has been
pursued with success in Ref. 4, where the single-pool
minimal models have interpreted cold and hot glucose
data during an experiment in which insulin remained
basal and glucose exhibited a prandial profile. Further
studies are warranted to more fully explore both of
these approaches.
APPENDIX A: TWO-COMPARTMENT SIMULATION
MODEL OF THE IVGTT
Here we describe the two-compartment model used for
simulating cold and hot glucose data during the hot IVGTT.
Because cold glucose concentration is the result of the balance
between Rd and EGP, both of these processes are described by
the model. To describe Rd, we use a two-compartment model,
which has been shown to provide a physiological description
of glucose kinetics during the IVGTT (14, 37, 39). This model,
shown in Fig. 5, has already been described in Refs. 14, 37,
and 39; it builds on the two-compartment structure exten-
sively analyzed in Ref. 21. Briefly, the accessible pool compre-
hends tissues that are in rapid equilibrium with plasma, like
red blood cells, central nervous system, kidneys, and liver.
These tissues consume glucose largely in an insulin-depen-
dent way. The second pool comprehends tissues that equili-
brate more slowly, with plasma, like muscle and fat. These
tissues are mainly insulin dependent. This is the reason why
in the model insulin-independent glucose disposal is assumed
to take place in the accessible pool (pool 1), whereas insulin-
dependent glucose disposal is assumed to occur in the nonac-
cessible pool (pool 2). Insulin-independent glucose uptake has
two components, one constant and the other proportional to
glucose concentration. Thus the fractional disappearance
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rate of the accessible pool is
k01(t) 5 kd 1
Rd,0
V1g(t)
(A1)
where kd accounts for the proportional term, and Rd,0 is the
nonzero intercept of the steady-state relationship Rd vs. g.
Because k01 decreases as glucose concentration increases, the
model accounts for the well-known inhibitory effect of hyper-
glycemia on its own clearance (11, 12, 36).
Insulin-dependent glucose disposal is described by a para-
metric control on k02
k02(t) 5 k02 1 xd(t) (A2)
where xd(t) is insulin action on glucose uptake originating
from an insulin compartment remote from plasma. The
dynamics of xd(t) is governed by parameters kbd and ka, which
describe the transport of plasma insulin into the compart-
ment and the removal of remote insulin from the compart-
ment, respectively.
Physiological knowledge indicates that, in the basal state,
one-fourth of glucose uptake is due to insulin-dependent
glucose tissues and three-fourths to insulin-independent glu-
cose tissues (21). This yields the following relationship among
the parameters of the model
kd 1
Rd,0
gbV1
5
3k21k02
k02 1 k12
(A3)
The model description of EGP during the IVGTT employs
the same functional description embodied in the cold minimal
model (8, 17, 19, 23). In fact, inhibition of EGP is assumed to
be proportional to the glucose excursion above basal and to
the product of glucose concentration and insulin action on
EGP, xp(t), assumed to occur with the same timing as insulin
action on Rd. This is the reason why the remote insulin
compartments from which xp(t) and xd(t) originate have the
same rate constant, ka. In contrast, parameters kbd and kbp are
different, with kbd being higher than kbp, because it is known
from clamp studies that insulin effect is greater on Rd than on
EGP.
The model equations for cold and hot glucose are
where qi(t) and q*i(t) (i 5 1, 2) are, respectively, the cold and
hot glucose masses in the ith compartment of the model.
The values of the model parameters are reported in Table A1.
The values of V1, k21, k12, and k02 were taken from Ref. 21; Rd,0
was chosen to be equal to the value experimentally determined in
Ref. 12; kd was determined from Eq. A3; kp was calculated with
the assumption that glucose effectiveness on EGP is one-third of
overall glucose effectiveness (11); parameter ka was taken from
Ref. 14; parameters kbd and kbp were chosen in such a way that
the two-compartment model values of insulin sensitivity related
to Rd 1 EGP and to Rd only were equal to the analogous clamp-
based values reported by Saad et al. (32) in normal subjects.
APPENDIX B: MONTE CARLO SIMULATION OF A HOT IVGTT
To obtain minimal model indexes that could be compared
with the corresponding indexes of the two-compartment
model, we resorted to Monte Carlo simulation. The two-
compartment model equations were used to generate noise-
q˙1(t) 5 2 3kd 1 Rd,0q1(t) 1 k214 q1(t) 1 k12q2(t) 1 EGP(t) q1(0) 5 D 1 q1b
q˙2(t) 5 2 [k02 1 xd(t) 1 k12]q2(t) 1 k21q1(t) q2(0) 5 q1b[k21/(k02 1 k12)]
q*1(t) 5 2 3kd 1 Rd,0q1(t) 1 k214 q*1(t) 1 k12q*2(t) q*1(0) 5 D*
q˙*2(t) 5 2 [k02 1 xd(t) 1 k12]q*2(t) 1 k21q*1(t) q*2(0) 5 0
EGP(t) 5 5
EGPb 2 kp[q1(t) 2 q1b] 2 xp(t)q1(t) if EGP(t) . 0
0 otherwise
x˙d(t) 5 2 kaxd(t) 1 kbd[i(t) 2 ib] xd(0) 5 0
x˙p(t) 5 2 kaxp(t) 1 kbp[i(t) 2 ib] xp(0) 5 0
g(t) 5
q1(t)
V1
g*(t) 5
q*1(t)
V1
(A4)
Table A1. Two-compartment model parameters
Parameter Units Value
Glucose subsystem
V1 dl/kg 1.58
VT dl/kg 2.63
k21 min21 0.043
k12 min21 0.059
k02 min21 0.006
kd min21 0.0049
kp min21 0.0044
Rd,0 mg·kg21 ·min21 1.0
gb mg/dl 90
D mg/kg 330
D* dpm/kg 1,500,000
Insulin subsystem
ka min21 0.045
kbd 31025 min22 ·µU·ml21 3.76
kbp 31026 min22 ·µU·ml21 6.49
ib µU/ml 7
See glossary for explanation of parameters.
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free cold and hot glucose data during a hot IVGTT. The mean
insulin profile of either a standard or an insulin-modified
IVGTT was used as input to the model (Fig. B1). It is of
interest that the profiles of EGP generated in both occasions
always assumed positive values, implying that it was not neces-
sary to force EGP to be nonnegative. Subsequently, 200 realiza-
tions of noisy cold and hot glucose data were obtained by
adding measurement noise of appropriate statistical charac-
teristics to the noise-free data. Specifically, for cold (g, mg/dl)
and hot (g*, dpm/ml) glucose concentration, measurement
noise was assumed to be independent, gaussian, and with a zero
mean and standard deviations of 0.02 g and 3010.018 g*, re-
spectively. Each noisy data set was analyzed with the cold
and hot minimal models. The cold minimal model was identified
from cold glucose and insulin data and the hot minimal model
from hot glucose and insulin data via nonlinear weighted
least squares (13), with weights chosen optimally, i.e., equal
to the inverse of the variance of the measurement error. As is
usually done in practice, to mitigate the error of the single-
compartment assumption, cold and hot glucose data up to 10 min
after the glucose bolus were ignored in model identification. For
the cold model, the value of gb was chosen to be equal to the
mean of the last two glucose data (at 210 and 240 min). Each
noisy data set yielded an estimate of fractional indexes SG, SI,
S*G, and S*I, and volumes V and V*. Results for the standard and
insulin-modified IVGTT have been reported in Table 1.
APPENDIX C: TWO-COMPARTMENT MODEL INDEXES OF
GLUCOSE EFFECTIVENESS AND INSULIN SENSITIVITY
Here we outline how indexes of cold and hot glucose
effectiveness and insulin sensitivity can be derived from the
parameters of the two-compartment model. For the sake of
clarity, we first provide their definitions.
Cold glucose effectiveness is defined as the ability of
glucose to promote its own disappearance by stimulating Rd
and inhibiting EGP. It can be expressed mathematically as
the derivative of Rd1EGP with respect to glucose concentra-
tion at basal steady state
Cold glucose effectiveness 0
d[Rd(t) 1 EGP(t)]
dg(t) 0SS (C1)
Hot glucose effectiveness measures glucose effect on Rd only
and is defined as
Hot glucose effectiveness 0
dRd(t)
dg(t) 0SS (C2)
Insulin sensitivity is defined as the ability of insulin to
enhance glucose effectiveness. Whereas cold insulin sensitiv-
ity measures insulin effect on both Rd and EGP, hot insulin
sensitivity refers to Rd only
Cold insulin sensitivity 0
d2[Rd(t) 1 EGP(t)]
dg(t)di(t) 0SS (C3)
Hot insulin sensitivity 0
d2Rd(t)
dg(t)di(t) 0SS (C4)
Plasma clearance rate is the ratio between Rd and plasma
glucose concentration at steady state
Plasma clearance rate 0
Rd(t)
g(t) 0SS (C5)
Applying the above definitions to the two-compartment model
described in APPENDIX A, one obtains indexes measuring cold
and hot glucose effectiveness and insulin sensitivity and
basal plasma clearance rate (GE, GE*, IS, IS*, and PCR).
Details on the formal derivation of the indexes can be found in
Vicini et al. (37). The expressions of the two-compartment
model indexes are reported in Table C1.
In comparing the minimal model indexes obtained from the
Monte Carlo simulation (Table 1) with the corresponding
indexes of the two-compartment model, one is faced with the
problem that the units are different. For instance, SG is
expressed in min21, whereas the two-compartment model
glucose effectiveness, GE, is expressed in milligrams per
kilogram per minute. As a matter of fact, the minimal model
indexes SG, SI, S*G, and S*I are all fractional indexes, i.e., they
refer to a unit of glucose distribution volume. As shown in Ref.
37, to convert the minimal model indexes to the same units of
the two-compartment model indexes, the cold and hot indexes
must be multiplied by the cold and hot minimal model
volumes V and V*, respectively. The expressions of the
minimal model indexes multiplied by the respective volumes
are reported in Table C1. It is worth mentioning that, for the
Fig. B1. Insulin profiles used in Monte Carlo simulation to assess the
effect of insulin dynamics during the IVGTT on cold and hot minimal
model indexes. Insulin profiles A and B are typical of a standard and
an insulin-modified hot IVGTT, respectively.
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two-compartment model, glucose effectiveness and basal
plasma clearance rate are different because Rd is not propor-
tional to g, thus determining the presence of the nonzero
intercept Rd,0. In contrast, because the hot minimal model
assumes that Rd is proportional to g, one has Rd,0 5 0, and
glucose effectiveness and clearance rate coincide.
Cold and hot glucose effectiveness and insulin sensitivity
can also be assessed under steady-state conditions by use of
the glucose clamp technique (7, 11). Glucose effectiveness is
measured from hyperglycemic clamps at basal insulin,
whereas insulin sensitivity is measured from hyperinsulin-
emic, euglycemic clamps. The clamp-based indexes are thus
derived on the basis of finite (D), rather than differential (d),
increments of glucose and insulin. Their expressions are
reported in Table C1. As one can see, although the cold
indexes reflect changes in the glucose infusion rate, GINF,
and thus in both Rd and EGP, the hot indexes reflect changes
in Rd only.
APPENDIX D: TWO-COMPARTMENT MODEL
SIMULATION OF AN IVGTT AT BASAL INSULIN
The purpose here is to use the two-compartment model to
describe the time courses of cold and hot glucose during a hot
IVGTT in which insulin is maintained at the basal level.
Cold Glucose Decay
When insulin remains at the basal level throughout the
IVGTT, insulin action is identically null and the two-
compartment model equations for cold glucose become
In the basal steady state, EGP equals Rd and thus
EGPb 5 Rdb 5 PCRbgb 5 V1 3kp 1 Rd,0V1gb 1
k21k02
(k02 1 k12)4 gb (D2)
Substitution of EGPb given by Eq. D2 into Eq. D1 permits
elimination of the term containing Rd,0. Using the position
Dqi(t) 5 qi(t) 2 qib for i 5 1, 2, one obtains
Dq˙1(t) 5 2[kd 1 kp 1 k21]Dq1(t) 1 k12Dq2(t) 1 Dd(t)
Dq1(0) 5 0
Dq˙2(t) 5 2[k02 1 k12]Dq2(t) 1 k21Dq1(t) (D3)
Dq2(0) 5 0
Dg(t) 5
Dq1(t)
V1
where d(t) is the Dirac impulse function. Equation D3 indi-
cates that, during an IVGTT at basal insulin, glucose decay
above the baseline is the impulse response of a linear,
second-order system with constant parameters. As a result,
glucose decay is two-exponential
Dg(t) 5 D(A1e2l1t 1 A2e2l2t) (D4)
where l1 and l2 are the fast and slow eigenvalues, respec-
tively. Of note is that A1, A2, l1, and l2 reflect the ability of
glucose not only to promote Rd but also to inhibit EGP. Their
values, reported in Table D1, have been derived from the
two-compartment model parameters (Table A1) by calculat-
ing the transfer function of the system described by Eq. D3
and equating it to the Laplace transform of the two-
exponential decay of Eq. D4 (13).
The fractional decay rate of incremental glucose concentra-
tion, kG, which measures the fraction of glucose concentration
Table C1. Glucose effectiveness, insulin sensitivity, and basal plasma clearance rate for two-compartment model,
minimal models, and glucose clamp technique
Two-Compartment Model Minimal Models Glucose Clamp
Cold glucose effectiveness, ml·kg21 ·min21 GE 5 V11kd 1 kp 1 k21k02k02 1 k122 SG SG,d(clamp) 5
DGINF
Dg 0i5ib
Hot glucose effectiveness, ml·kg21 ·min21 GE* 5 V11kd 1 k21k02k02 1 k122 S*GV* SG(clamp) 5
DRd
Dg 0i5ib†
Cold insulin sensitivity, ml·kg21 ·min21 · µU21 ·ml IS 5 V151
kbp
ka 2 1
kbd
ka 3
k21k12
(k02 1 k12)246 SIV SI(clamp) 5
DGINF
gDi 0g5gb
Hot insulin sensitivity, ml·kg21 ·min21 · µU21 ·ml IS* 5 V11
kbd
ka 23
k21k12
(k02 1 k12)24 S*IV* SI,d(clamp) 5
DRd
gDi 0g5gb
Basal plasma clearance rate, ml·kg21 ·min21 PCRb 5 V11kd 1 Rd,0V1gb 1
k21k02
k02 1 k122 S*GV*
PCRb 5
Rd
g 0g5gb
†In steady state, Rd 5 (g/g*)INF*, where INF* is tracer infusion rate.
q˙1(t) 5 2 3kd 1 Rd,0q1(t) 1 k214 q1(t) 1 k12q2(t) 1 EGPb 2 kp[q1(t) 2 q1b] q1(0) 5 D 1 q1b
q˙2(t) 5 2[k02 1 k12]q2(t) 1 k21q1(t) q2(0) 5 q1b[k21/(k02 1 k12)] (D1)
g(t) 5
q1(t)
V1
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above basal that declines per unit time, is given by
kG(t) 5 2
Dg˙(t)
Dg(t)
5
(A1l1e2l1t 1 A2l2e2l2t)
(A1e2l1t 1 A2e2l2t)
(D5)
Hot Glucose Decay
During a hot IVGTT at basal insulin, the two-compartment
model equations for hot glucose become
q˙*1(t) 5 2 3kd 1 Rd,0q1(t) 1 k214 q*1(t) 1 k12q*2(t) 1 D*d(t)
q*1(0) 5 0
q˙*2(t) 5 2[k02 1 k12]q*2(t) 1 k21q*1(t) (D6)
q*2(0) 5 0
g*(t) 5
q*1(t)
V1
If Rd,0 were equal to zero, the system described by Eq. D6
would be linear, and the decay of hot glucose concentration
after the (cold 1 hot) glucose injection would coincide with the
two-exponential impulse response of glucose kinetics in the
basal steady state
g*(t) 5 D*(A*1e2l*1t 1 A*2e2l*2t) (D7)
where l*1 and l*2 are the fast and slow eigenvalues of glucose
kinetics in the basal state. Of note is that parameters A*1, A*2,
l*1, and l*2 reflect Rd only. Their values, reported in Table D1,
have been derived from the two-compartment model param-
eters by calculating the transfer function of the linear system
described by Eqs. D6 with Rd,0 5 0 and equating it to the Laplace
transform of the two-exponential decay of Eq. D7 (13).
However, because Rd,0 is greater than zero, hot glucose
decay is not two-exponential
g*(t) 5 D*(A*1e2l*1t 1 A*2e2l*2t) 1 a(t) (D8)
where the term a(t) is the deviation of the true hot glucose
decay from the two-exponential function of Eq. D7. The
fractional decay rate of hot glucose during the IVGTT at basal
insulin, k*G(t), is the ratio g(t˙)*/g(t). The time course of k*G(t)
has been shown in Fig. 8.
APPENDIX E: SG(CLAMP) FROM THE PARAMETERS
OF THE TWO-COMPARTMENT MODEL
Here we show that the clamp-based measure of glucose
effectiveness, SG(clamp), can be expressed as a function of the
parameters of the two-compartment model and is related to
the area under the glucose decay curve during an IVGTT at
basal insulin.
SG(clamp) and the Two-Compartment Model
SG(clamp) is measured from hyperglycemic clamp studies in
which glucose concentration is elevated via an exogenous
glucose infusion rate, and insulin concentration is main-
tained at the basal level (11). By applying the formal defini-
tion of glucose effectiveness reported in Eq. C1 to a hypergly-
cemic clamp at basal insulin, one finds that SG(clamp)
corresponds to the slope of the steady-state relationship
between the exogenous glucose infusion rate, GINF, and
plasma glucose concentration
SG(clamp) 5
D(Rd 2 EGP)
Dg 0i5ib 5
DGINF
Dg 0i5ib (E1)
To express SG(clamp) as a function of the parameters of the
two-compartment model, one must write the two-compart-
ment model equations describing glucose dynamics during a
hyperglycemic glucose clamp at basal insulin. They are the
same as those derived in APPENDIX D for an IVGTT at basal
insulin except that the exogenous glucose input is a variable
glucose infusion, GINF(t), instead of a bolus injection
Dq˙1(t) 5 2[kd 1 kp 1 k21]Dq1(t) 1 k12Dq2(t) 1 GINF(t)
Dq1(0) 5 0
Dq˙2(t) 5 2[k02 1 k12]Dq2(t) 1 k21Dq1(t) (E2)
Dq2(0) 5 0
Dg(t) 5
Dq1(t)
V1
When an elevated steady state for glucose is achieved, the
derivatives of Dq1 and Dq2 become null, and Eq. E2 yields the
following relationship between DGINF and Dg
DGINF 5 DgV13kd 1 kp 1 k21k02(k02 1 k12)4 (E3)
By substituting Eq. E3 into Eq. E1, one obtains
SG(clamp) 5 V1 3kd 1 kp 1 k21k02(k02 1 k12)4 (E4)
It is of interest that the expression of SG(clamp) in Eq. E4 is
identical to the index of cold glucose effectiveness, GE, of the
two-compartment model (see Table C1).
SG(clamp) and the IVGTT at Basal Insulin
SG(clamp) can also be expressed as a function of the impulse
response parameters A1, A2, l1, and l2, which describe glucose
decay during an IVGTT at basal insulin. To do so one has to
integrate from zero to infinity Eq. D3, which describes the
glucose glucose system during an IVGTT at basal insulin
AUC[Dg(t)] 5
D
V1 3kd 1 kp 1 k21k02(k02 1 k12)4
(E5)
Because Dg(t) is a two-exponential impulse response,
AUC[Dg(t)] can also be expressed as a function of the impulse
Table D1. Parameters of cold and hot glucose decay
during a hot IVGTT at basal insulin
Parameter Units Value
Cold glucose
A1 kg/ml 0.0028
A2 kg/ml 0.0036
l1 min21 0.1094
l2 min21 0.0079
Hot glucose
A*1 kg/ml 0.0029
A*2 kg/ml 0.0035
l*1 min21 0.1106
l*2 min21 0.0093
See glossary for explanation of parameters.
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response parameters A1, A2, l1, and l2
AUC[Dg(t)] 5
D
1A1l1 1
A2
l2
2
(E6)
By equating Eqs. E5 and E6 and remembering that the
denominator of Eq. E5 is equal to SG(clamp) (see Eq. E4), one
obtains
SG(clamp) 5
D
AUC[Dg(t)]
5
1
1A1l1 1
A2
l2
2
(E7)
APPENDIX F: INSULIN ACTION AND INSULIN
SENSITIVITY OF THE MINIMAL MODELS
The purpose of this appendix is to investigate the relation-
ships between insulin action and sensitivity of the two-
compartment model and the minimal models.
In the two-compartment model, xd(t) is insulin action on
glucose disposal, and xp(t) is insulin action on glucose produc-
tion. The overall insulin action of the two-compartment model
is thus X(t) 5 xp(t)1xd(t). The insulin action of the cold
minimal model, x(t), differs from X(t) for two reasons: the
different model order (1 vs. 2 compartments) and the compart-
ment where insulin action takes place (accessible vs. nonacces-
sible). To single out the effect of the monocompartmental
approximation on x(t), an ‘‘accessible-pool equivalent’’ profile
of insulin action, denoted as X˜(t), has been derived. X˜(t) 5
xp(t) 1 x˜d(t), where x˜d(t) is the profile of insulin action on
glucose uptake that, placed in the accessible pool of the
two-compartment model, produces the same effect as xd(t) on
plasma glucose concentration. Application of this definition to
the two-compartment model (Eq. A4) leads to the following
expression for x˜d(t)
x˜d(t) 5 k12
[q˜2(t) 2 q2(t)]
q1(t)
(F1)
where q˜2(t) is glucose mass in the second compartment when
the insulin-dependent glucose removal is moved to the acces-
sible pool. Calculation of q˜2(t) requires solution of the mass-
balance equation of the nonaccessible glucose pool (second
equation in A4) without the insulin-dependent term
q˙˜2(t) 5 2[k02 1 k12]q˜2(t) 1 k21q1(t);
q˜2(0) 5 q1b[k21/(k02 1 k12)]
(F2)
Eq. F1 shows that x˜d(t) is such that the increase in the flux
irreversibly leaving the accessible compartment, x˜d(t)q1(t),
exactly compensates the increase in the flux coming from the
nonaccessible compartment. As a result, the time course of
glucose concentration in the accessible pool remains un-
changed.
The difference Dx(t) 5 X˜(t)2 x(t) is the bias affecting the
minimal model insulin action due to monocompartmental
undermodeling. Dx(t) can be given an analytic expression by
assuming that the minimal model is able to perfectly describe
the glucose decay generated by the two-compartment model.
In this case, Dx(t) can be derived by equating the expressions
of the glucose fractional decay rate yielded by the two models.
The fractional decay rate of glucose concentration of the
minimal model is made up of two components, one depending
on insulin action and the other on glucose effectiveness (18)
g˙(t)
g(t)
5
dln[g(t)]
dt
2 3x(t) 1 SG Dg(t)g(t) 4 (F3)
The fractional decay rate of the two-compartment model can
be calculated from Eq. A1
g˙(t)
g(t)
5
dln[g(t)]
dt
5 2 3X˜(t) 1 GEV1
Dg(t)
g(t)
1
g
(k22)2
g˙˜2(t)
g(t) 4 (F4)
where g 5 k21k12, k22 5 (k021k12), and g˜2(t) is glucose
concentration in the second nonaccessible pool. Its structure
is similar to the one of the minimal model except for an
additional term proportional to the ratio between the deriva-
tive of glucose concentration in the nonaccessible pool and
glucose concentration in the accessible pool. By equating Eqs.
F3 and F4 one obtains an expression for Dx(t)
Dx(t) 5 X˜(t) 2 x(t) 5 2 31GEV1 2 SG2
Dg(t)
g(t)
1
g
(k22)2
g˙˜2(t)
g(t) 4 (F5)
Equation F5 shows that the bias affecting the minimal model
insulin action has two components: the first is proportional to
the minimal model underestimation of fractional glucose
effectiveness, whereas the second is modulated by the rate of
change of glucose concentration in the nonaccessible pool,
normalized to glucose concentration in the accessible pool.
The bias affecting x(t) influences the accuracy of SI. In Ref.
18 we have shown that SI is proportional to the integral of
insulin action
S1 5
e
0
‘
x(t) dt
e
0
‘
[i(t) 2 ib]
(F6)
The fractional insulin sensitivity of the two-compartment
model, IS/V1, is well approximated by the integral of X˜(t)
normalized to the area under the insulin concentration curve
(6.46 vs. 6.52 min21 ·µmol21 ·ml). The agreement is not per-
fect because X˜(t), being the accessible-pool equivalent of the
two-compartment model insulin action, does not satisfy, like
the minimal model insulin action x(t) (Eq. 1), the equation of
a remote insulin compartment. The difference between the
two-compartment and the cold minimal model estimates of
insulin sensitivity is thus well approximated by
D*S1 5
IS
V1
2 S1 <
AUC[Dx(t)]
AUC[i(t) 2 ib]
(F7)
Analogous expressions for the difference between the two-
compartment and the hot minimal model insulin action and
insulin sensitivity can be derived by following an approach
similar to that just outlined for the cold model. D*x, which is
the difference between the two-compartment insulin action
on Rd (applied to the accessible pool) and the hot minimal
model insulin action, is given by
D*x(t) 5 x˜*d(t) 2 x*(t)
5 2 31GE*V1 2 S*G2 1
g
(k22)2
g˙˜*2(t)
g*(t)
1
Rd,0
V1g(t)4
(F8)
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where x˜*d(t) is the ‘‘accessible-pool equivalent’’ profile of two-
compartment insulin action on glucose disposal calculated
from tracer data. x˜*d(t) is calculated from the two-compart-
ment model (Eq. A1) so as to produce the same effect on hot
glucose concentration as xd(t); GE*/V1 is fractional hot glu-
cose effectiveness of the two-compartment model; g˜*2(t) is hot
glucose concentration in the nonaccessible glucose pool when
insulin-dependent glucose removal takes place in the acces-
sible pool. The expression of D*x(t) is similar to that of Dx(t) but
includes an additional term proportional to Rd,0 that accounts
for the fact that the hot minimal model does not describe the
inhibitory effect of glucose on its own clearance. DS*I, i.e., the
difference between the (fractional) insulin sensitivity on Rd of
the two-compartment model and S*I, can be calculated as
previously done for SI
DS*I 5
IS*
V1
2 S*I <
AUC[D*x(t)]
AUC[i(t) 2 ib]
(F9)
where the hot fractional insulin sensitivity of the two-
compartment model, IS*/V1, is well approximated by the
integral of x˜*d(t) normalized to the area under the insulin
concentration curve (5.02 vs. 5.78 min21 ·µmol21 ·ml). The
agreement is not perfect because x˜*d(t), the tracer-based
accessible-pool equivalent of the two-compartment model
insulin action on glucose disposal, does not satisfy, as the
minimal model insulin action x*(t) (Eq. 2), the equation of a
remote insulin compartment.
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